Denagliptin

DB16134InvestigationalSmall molecule

Denagliptin is under investigation in clinical trial NCT00387972 (Study of Denagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM)).

Chemical structure of Denagliptin
Formula / weight
C20H18F3N3O · 373.379 g/mol (avg)

Resolves to

Compound
UNIIDOS9ZOT21LCAS483369-58-0ChEMBLCHEMBL2110666
Structure
InChIKeyURRAHSMDPCMOTH-LNLFQRSKSA-NSMILESN[C@@H](C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1)C(=O)N1C[C@@H](F)C[C@H]1C#N
Targets
P27487DPP4

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Denagliptin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In